CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood

Topics

Biology

Cancer Oncology

Medicine

Immunology

Dermatology

Show all topics

DOI

10.1182/blood-2012-10-461848